Ohioans must recognize the threat that vertically-integrated insurance conglomerates pose to our health and pocketbooks.

The usual PBM strategy cuts an independent pharmacy's share of the prescription revenue to just 3 cents per pill dispensed, ...

The owner of one of the three largest pharmacy middlemen in the United States last month filed suit to quash an attempt by the Federal Trade Commission to investigate industry ...

A pharmacy benefit manager ... Trade Commission (FTC), taking issue with the agency's recent report accusing PBMs of using anti-competitive practices to drive up prescription drug prices.

In a letter (PDF) to FTC chair ... two other drugs used to treat type 2 diabetes in the […] Orange Book, which resulted in a warning letter from the FTC." She has asked the FTC to sue to block ...

Elizabeth Warren seeks scrutiny of deals that would allow drug middlemen McKesson, Cardinal Health, and Cencora to also ...

The FTC’s Democrats hoped that unanimous, bipartisan support for the merger rules would make business groups less likely to ...

The information requests from the FTC, combined with new state laws bolstering oversight of healthcare deals, have delayed transaction closing dates. However, the agency has yet to formally ...

McKesson, Cardinal Health, and Cencora are the three dominant wholesalers that distribute drugs and medical products. But they have prioritized becoming more than middlemen by also becoming cancer ...

Amid a growing cavalcade of Biden/Harris administrative agency miscues and misdeeds, a letter from Republican Senators Tom ...